Business Description
Stryker Corp
NAICS : 339112
SIC : 3841
ISIN : BRS1YKBDR002
Share Class Description:
BSP:S1YK34: BRDRCompare
Compare
Traded in other countries / regions
SYK.USAS1YK34.BrazilSYK.GermanySYK.MexicoSYK.AustriaSYK.Switzerland0R2S.UK IPO Date
2020-01-27Description
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.11 | |||||
| Equity-to-Asset | 0.46 | |||||
| Debt-to-Equity | 0.75 | |||||
| Debt-to-EBITDA | 2.86 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.61 | |||||
| Beneish M-Score | -2.42 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.2 | |||||
| 3-Year EBITDA Growth Rate | 2.9 | |||||
| 3-Year EPS without NRI Growth Rate | 4 | |||||
| 3-Year FCF Growth Rate | 9.5 | |||||
| 3-Year Book Growth Rate | 8.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 8.88 | |||||
| Future 3-5Y Total Revenue Growth Rate | 7.76 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.03 | |||||
| 9-Day RSI | 39.8 | |||||
| 14-Day RSI | 43.79 | |||||
| 6-1 Month Momentum % | -3.18 | |||||
| 12-1 Month Momentum % | 28.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.54 | |||||
| Quick Ratio | 0.84 | |||||
| Cash Ratio | 0.22 | |||||
| Days Inventory | 207.23 | |||||
| Days Sales Outstanding | 61.12 | |||||
| Days Payable | 65.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.07 | |||||
| Dividend Payout Ratio | 0.41 | |||||
| 3-Year Dividend Growth Rate | 9.9 | |||||
| Forward Dividend Yield % | 1.07 | |||||
| 5-Year Yield-on-Cost % | 1.74 | |||||
| 3-Year Average Share Buyback Ratio | -0.4 | |||||
| Shareholder Yield % | 1.14 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.79 | |||||
| Operating Margin % | 18.03 | |||||
| Net Margin % | 13.92 | |||||
| ROE % | 16.32 | |||||
| ROA % | 7.4 | |||||
| ROIC % | 9.63 | |||||
| ROC (Joel Greenblatt) % | 54.63 | |||||
| ROCE % | 11.29 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 38.68 | |||||
| Forward PE Ratio | 23.92 | |||||
| PE Ratio without NRI | 38.68 | |||||
| Shiller PE Ratio | 49.26 | |||||
| Price-to-Owner-Earnings | 46.22 | |||||
| PEG Ratio | 9.43 | |||||
| PS Ratio | 5.39 | |||||
| PB Ratio | 5.99 | |||||
| Price-to-Free-Cash-Flow | 43.35 | |||||
| Price-to-Operating-Cash-Flow | 34.64 | |||||
| EV-to-EBIT | 32.94 | |||||
| EV-to-Forward-EBIT | 24.2 | |||||
| EV-to-EBITDA | 25.53 | |||||
| EV-to-Forward-EBITDA | 19.65 | |||||
| EV-to-Revenue | 5.94 | |||||
| EV-to-Forward-Revenue | 5.18 | |||||
| EV-to-FCF | 47.77 | |||||
| Price-to-Projected-FCF | 2.77 | |||||
| Price-to-DCF (Earnings Based) | 2.35 | |||||
| Price-to-DCF (FCF Based) | 3.26 | |||||
| Price-to-Median-PS-Value | 1.13 | |||||
| Earnings Yield (Greenblatt) % | 3.04 | |||||
| Forward Rate of Return (Yacktman) % | 7.14 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Stryker Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil R$) | 99,908.431 | ||
| EPS (TTM) (R$) | 1.816 | ||
| Beta | -0.03 | ||
| Volatility % | 25.41 | ||
| 14-Day RSI | 43.79 | ||
| 14-Day ATR (R$) | 0.45943 | ||
| 20-Day SMA (R$) | 70.6845 | ||
| 12-1 Month Momentum % | 28.41 | ||
| 52-Week Range (R$) | 53.16 - 76.8 | ||
| Shares Outstanding (Mil) | 7,595.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Stryker Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Stryker Corp Stock Events
| Event | Date | Price(R$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Stryker Corp Frequently Asked Questions
What is Stryker Corp(BSP:S1YK34)'s stock price today?
The current price of BSP:S1YK34 is R$69.36. The 52 week high of BSP:S1YK34 is R$76.80 and 52 week low is R$53.16.
When is next earnings date of Stryker Corp(BSP:S1YK34)?
The next earnings date of Stryker Corp(BSP:S1YK34) is 2023-10-31 Est..
Does Stryker Corp(BSP:S1YK34) pay dividends? If so, how much?
The Dividend Yield %  of Stryker Corp(BSP:S1YK34) is 1.07% (As of Today), Highest Dividend Payout Ratio of Stryker Corp(BSP:S1YK34) was 0.94. The lowest was 0.21. And the median was 0.44. The  Forward Dividend Yield % of Stryker Corp(BSP:S1YK34) is 1.07%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers